Aim To find out a cost-efficient strategy for HNPCC molecular diagnostic screening. 2-3% of all colorectal cancers and is an autosomal dominant cancer predisposition syndrome caused primarily by inactivating mutations in one of the genes involved in DNA mismatch restoration (MMR), most commonly MLH1 and MSH2 [1-3]. HNPCC is definitely characterised clinically by an early… Continue reading Aim To find out a cost-efficient strategy for HNPCC molecular diagnostic